SEARCH

SEARCH BY CITATION

References

  • 1
    Silberstein JL, Vickers AJ, Power NE et al. Reverse stage shift at a tertiary care center: escalating risk in men undergoing radical prostatectomy. Cancer 2011; 117: 48554860
  • 2
    Swanson GP, Goldman B, Tangen CM et al. The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from southwest oncology group 8794. J Urol 2008; 180: 24532458
  • 3
    Nepple KG, Rosevear HM, Stolpen AH, Brown JA, Williams RD. Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients. Urol Oncol 2011; [Epub ahead of print]. doi: 10.1016/j.urolonc.2011.05.004
  • 4
    Gallina A, Chun FKH, Briganti A et al. Development and Split-Sample Validation of a Nomogram Predicting the Probability of Seminal Vesicle Invasion at Radical Prostatectomy. Eur Urol 2007; 52: 98105
  • 5
    Marks LB, Anscher MS. Radiotherapy for prostate cancer: should the seminal vesicles be considered target? Int J Radiat Oncol 1992; 24: 435440
  • 6
    Diaz A, Roach M, Marquez C et al. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol 1994; 30: 323329
  • 7
    Stock RG, Lo YC, Gaildon M, Stone NN. Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined PD-103 prostate implantation and external beam irradiation. Int J Radiat Oncol 1999; 45: 385389
  • 8
    Shipley WU, Thames HD, Sandler HM et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999; 281: 15981604
  • 9
    Zagars GK, Pollack A, von Eschenbach AC. Prostate cancer and radiation therapy – the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol 1995; 33: 2335
  • 10
    Stephenson AJ. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol 2005; 23: 81988203
  • 11
    Chade DC, Shariat SF, Cronin AM et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 2011; 60: 205210
  • 12
    Pierorazio PM, Ross AE, Schaeffer EM et al. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy. J Urol 2011; 185: 16911697
  • 13
    Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004; 172: 22392243
  • 14
    Zlotta AR, Roumeguère T, Ravery V et al. Is Seminal Vesicle Ablation Mandatory for All Patients Undergoing Radical Prostatectomy? Eur Urol 2004; 46: 4249
  • 15
    Stone NN, Skouteris VM, Stock RG. Biopsy and implantation of the seminal vesicles. Brachytherapy 2012; 11: 334340
  • 16
    Frank SJ, Dong L, Kudchadker RJ et al. Quantification of Prostate and Seminal Vesicle Interfraction Variation During IMRT. Int J Radiat Oncol 2008; 71: 813820
  • 17
    Benk VA, Adams JA, Shipley WU et al. Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3–T4 prostate carcinoma. Int J Radiat Oncol 1993; 26: 551557
  • 18
    Sala E, Eberhardt SC, Akin O et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006; 238: 176183
  • 19
    Allepuz Losa CA, Sanz Velez JI, Gil Sanz MJ, Mas LP, Rioja Sanz LA. Seminal vesicle biopsy in prostate cancer staging. J Urol 1995; 154: 14071411
  • 20
    Stone NN, Stock RG, Unger P. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 1995; 154: 13921396
  • 21
    Stock RG, Stone NN, Ianuzzi C, Unger P. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Radiat Oncol 1995; 33: 815821